Law.com Subscribers SAVE 30%

Call 855-808-4530 or email [email protected] to receive your discount on a new subscription.

Medical Malpractice Law & StrategyLJN NewslettersNewsSections

Health Reform Mandates Transparency in Industry/Provider Relationship

By Tracy E. Miller
February 28, 2011

National health care reform legislation adopted in March 2010 contained numerous provisions to promote transparency in the health care delivery system. Most significantly, ' 6002 of the legislation included provisions that comprised the Physician Payments Sunshine Act previously introduced as a separate bill (Sunshine Law). Patient Protection and Affordable Care Act, Pub.L.No. 111-148, 124 Stat. 119, amended by the Health Care and Education Reconciliation Act of 2010, Pub.L.No. 111-152, ' 6002. The Sunshine Law mandates public disclosure of payments and gifts by pharmaceutical, device, medical supply, and biotechnology companies to physicians and teaching hospitals for a wide array of purposes, including consulting, speaking engagements, advisory board service, travel, food, and clinical research. Part of a national movement to use disclosure to advance quality and compliance in health care delivery, the Sunshine Law has significant implications for health care providers and the public as well as industry.

Move Toward Disclosure

This premium content is locked for LJN Newsletters subscribers only

  • Stay current on the latest information, rulings, regulations, and trends
  • Includes practical, must-have information on copyrights, royalties, AI, and more
  • Tap into expert guidance from top entertainment lawyers and experts

For enterprise-wide or corporate acess, please contact Customer Service at [email protected] or 877-256-2473

Read These Next
The DOJ's Corporate Enforcement Policy: One Year Later Image

The DOJ's Criminal Division issued three declinations since the issuance of the revised CEP a year ago. Review of these cases gives insight into DOJ's implementation of the new policy in practice.

Use of Deferred Prosecution Agreements In White Collar Investigations Image

This article discusses the practical and policy reasons for the use of DPAs and NPAs in white-collar criminal investigations, and considers the NDAA's new reporting provision and its relationship with other efforts to enhance transparency in DOJ decision-making.

The DOJ's New Parameters for Evaluating Corporate Compliance Programs Image

The parameters set forth in the DOJ's memorandum have implications not only for the government's evaluation of compliance programs in the context of criminal charging decisions, but also for how defense counsel structure their conference-room advocacy seeking declinations or lesser sanctions in both criminal and civil investigations.

CLE Shouldn't Be the Only Mandatory Training for Attorneys Image

Each stage of an attorney's career offers opportunities for a curriculum that addresses both the individual's and the firm's need to drive success.

A defendant in a patent infringement suit may, during discovery and prior to a <i>Markman</i> hearing, compel the plaintiff to produce claim charts, claim constructions, and element-by-element infringement analyses.